Cullinan Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$933K Hold
2,300
0.06% 130
2025
Q1
$1.14M Hold
2,300
0.08% 123
2024
Q4
$1.2M Hold
2,300
0.08% 125
2024
Q3
$1.37M Hold
2,300
0.08% 126
2024
Q2
$1.27M Hold
2,300
0.07% 133
2024
Q1
$1.34M Hold
2,300
0.08% 135
2023
Q4
$1.22M Sell
2,300
-400
-15% -$212K 0.07% 138
2023
Q3
$1.37M Hold
2,700
0.08% 133
2023
Q2
$1.41M Hold
2,700
0.08% 143
2023
Q1
$1.56M Sell
2,700
-400
-13% -$231K 0.09% 134
2022
Q4
$1.71M Hold
3,100
0.09% 127
2022
Q3
$1.57M Buy
3,100
+100
+3% +$50.7K 0.1% 126
2022
Q2
$1.63M Buy
3,000
+1,600
+114% +$869K 0.1% 120
2022
Q1
$827K Hold
1,400
0.04% 152
2021
Q4
$934K Buy
1,400
+600
+75% +$400K 0.05% 144
2021
Q3
$457K Hold
800
0.03% 185
2021
Q2
$404K Buy
800
+200
+33% +$101K 0.02% 184
2021
Q1
$274K Buy
+600
New +$274K 0.02% 192
2018
Q2
Sell
-22,170
Closed -$4.58M 184
2018
Q1
$4.58M Buy
22,170
+360
+2% +$74.3K 0.35% 84
2017
Q4
$4.14M Sell
21,810
-285
-1% -$54.1K 0.3% 88
2017
Q3
$4.18M Sell
22,095
-3,385
-13% -$640K 0.32% 82
2017
Q2
$4.45M Sell
25,480
-2,900
-10% -$506K 0.35% 80
2017
Q1
$4.36M Buy
28,380
+5,500
+24% +$845K 0.36% 73
2016
Q4
$3.23M Buy
22,880
+1,100
+5% +$155K 0.27% 97
2016
Q3
$3.46M Buy
21,780
+3,270
+18% +$520K 0.3% 91
2016
Q2
$2.74M Sell
18,510
-3,720
-17% -$550K 0.22% 99
2016
Q1
$3.15M Buy
22,230
+3,200
+17% +$453K 0.27% 93
2015
Q4
$2.7M Sell
19,030
-9,350
-33% -$1.33M 0.24% 94
2015
Q3
$3.47M Buy
28,380
+160
+0.6% +$19.6K 0.32% 73
2015
Q2
$3.66M Buy
28,220
+150
+0.5% +$19.5K 0.3% 78
2015
Q1
$3.77M Buy
+28,070
New +$3.77M 0.29% 73